A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of Age
NCT04837482
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class
Conditions
Presbyopia
Interventions
DRUG:
AGN-190584
DRUG:
Vehicle
Sponsor
AbbVie